Anti-Cancer Agents in Medicinal Chemistry
Title:Meet Our Editorial Board Member
Volume: 20 Issue: 4
Author(s): Kyu Lim
Affiliation:
Export Options
About this article
Cite this article as:
Lim Kyu , Meet Our Editorial Board Member, Anti-Cancer Agents in Medicinal Chemistry 2020; 20 (4) . https://dx.doi.org/10.2174/187152062004200312130031
DOI https://dx.doi.org/10.2174/187152062004200312130031 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
4
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Novel Polygalacturonase-Inhibiting Protein (PGIP) from Lathyrus sativus L. Seeds
Protein & Peptide Letters Oral Nano-Delivery Systems for Colon Targeting Therapy
Pharmaceutical Nanotechnology Polymers and Drug Delivery Systems
Current Drug Delivery Cytokines: From Gut Inflammation to Colorectal Cancer
Current Drug Targets Intestinal Absorption and Presystemic Elimination of Various Chemical Constituents Present in GBE50 Extract, a Standardized Extract of Ginkgo biloba Leaves
Current Drug Metabolism Fluorescence Imaging in Cancerology
Current Molecular Imaging (Discontinued) Potential Role of TRP Channels in Cough Hypersensitivity?
Current Respiratory Medicine Reviews Antiangiogenesis Drug Design: Multiple Pathways Targeting Tumor Vasculature
Current Medicinal Chemistry Supramolecular Nanomedicine - An Overview
Current Drug Targets Advances in Peptide Pharmaceuticals
Current Pharmaceutical Biotechnology Metabolomics Analysis for Biomarker Discovery: Advances and Challenges
Current Medicinal Chemistry Herb-drug Interactions Involving Drug Metabolizing Enzymes and Transporters
Current Drug Metabolism Target Therapies in Systemic Lupus Erythematosus: Current State of the Art
Mini-Reviews in Medicinal Chemistry Silver and Other Metals in the Treatment of Gastrointestinal Diseases
Current Medicinal Chemistry The Kinase Inhibitor Imatinib - An Immunosuppressive Drug?
Current Cancer Drug Targets Embryonic Stem Cell MicroRNAs: Defining Factors in Induced Pluripotent (iPS) and Cancer (CSC) Stem Cells?
Current Stem Cell Research & Therapy Synthetic and Natural Immunomodulators Acting as Interferon Inducers
Current Pharmaceutical Design 3D-QSAR and Docking Simulation Studies of Some Benzopyrone Derivatives as Inhibitors for Breast Cancer Stem Cell Growth via PGlycoprotein Mediated Efflux
Current Bioinformatics Targeting Different Pathways Using Novel Combination Therapy in Triple Negative Breast Cancer
Current Cancer Drug Targets DNA Recognition by a Novel Bis-Intercalator, Potent Anticancer Drug XR5944
Current Topics in Medicinal Chemistry